BBLCHROMAGAR MRSA— 510(k) K042812

Substantially Equivalent

Becton, Dickinson & CO

FDA 510(k) clearance K042812 for BBLCHROMAGAR MRSA, Substantially Equivalent on 2004-11-22. Applicant: Becton, Dickinson & CO.

Clearance details

Applicant: Becton, Dickinson & CO
Product code: Code JSO
Advisory panel: Microbiology
Date received: 2004-10-12
Decision date: 2004-11-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sparks, MD, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JSO

product code JSO

Malfunction: 602
Total: 602

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.